Rash News and Research

RSS

Scientists seeking blood donations from people exposed to arboviruses for dengue, Zika vaccine research

Researchers at the University of North Carolina School of Medicine are conducting studies that utilize blood donations from individuals who have been diagnosed with or potentially exposed to mosquito-borne viruses as part of ongoing dengue and Zika research and vaccine development.

2 Aug 2016

Dengue, chikungunya and Zika virus infections can be potential health threat to travelers

As the eyes of the world turn to Rio de Janiero for the 2016 Summer Olympics, the spread of the Zika virus in Brazil is a growing concern — but Zika is not the only disease that mosquitoes can spread to humans.

28 Jul 2016

Valley fever diagnosis often overlooked by primary care physicians

For patients with pneumonia or ongoing influenza-like symptoms who live in or have visited the west or southwest United States, especially Arizona and central California, infectious diseases experts recommend physicians suspect valley fever, an often-overlooked fungal infection.

28 Jul 2016

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.

6 Jul 2016

First-line nivolumab promising in advanced NSCLC

Phase I results published in the Journal of Clinical Oncology suggest that nivolumab, either given alone or alongside platinum-based doublet chemotherapy, could have a role in the first-line treatment of advanced non-small-cell lung cancer.

5 Jul 2016

Wolbachia bacterium can prevent mosquitoes from transmitting Zika virus

Researchers at the University of Wisconsin-Madison have confirmed that a benign bacterium called Wolbachia pipientis can completely block transmission of Zika virus in Aedes aegypti, the mosquito species responsible for passing the virus to humans.

1 Jul 2016

Researchers to explore how Zika virus enters human cells

A group of Western Illinois University student and faculty researchers are spending the summer conducting surveillance of tick-borne diseases and mosquito-borne arboviruses in regional counties.

25 Jun 2016

SLU to conduct human clinical trial of vaccine to protect people from Zika virus

Saint Louis University's vaccine center has been tapped by the National Institutes of Health to conduct a human clinical trial of a vaccine to prevent the Zika virus, which can cause devastating birth defects in babies.

24 Jun 2016

Anti-TNF therapy offers new hope to JDM patients

The results of a UK study presented today at the European League Against Rheumatism Annual Congress showed that tumour necrosis factor inhibitor (anti-TNF) treatment is effective at improving both muscle and skin involvement in children with juvenile dermatomyositis (JDM).

13 Jun 2016

Utah researchers find way to use power of protease to destroy budding AIDS virus

When new AIDS virus particles bud from an infected cell, an enzyme named protease activates to help the viruses mature and infect more cells. That's why modern AIDS drugs control the disease by inhibiting protease.

10 Jun 2016

Type 1 diabetes occurs more frequently in patients with JIA

The results of a study involving more than 9,000 patients, presented today at the European League Against Rheumatism Annual Congress showed that Type 1 diabetes occurs significantly more frequently in patients with Juvenile Inflammatory Arthritis (JIA) than in the general population.

10 Jun 2016

Zika virus directly infects brain progenitor cells in newborns to cause neurological problems

The mosquito-borne Zika virus linked to microcephaly and other neurological problems in newborns of affected mothers directly infects the brain progenitor cells destined to become neurons, UT Southwestern Medical Center researchers report in a study published online today in Cell Reports.

6 Jun 2016

Experimental drug Rova-T shows safety, efficacy in treating advanced SCLC patients

The experimental "smart-bomb" drug rovalpituzumab tesirine (Rova-T) appears safe and shows efficacy in treating patients with advanced small cell lung cancer (SCLC), according to results from a first-in-human clinical trial to be presented today by a Memorial Sloan Kettering Cancer Center researcher at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago.

6 Jun 2016

Nivolumab drug shows better response rate in metastatic bladder cancer patients

The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless of whether their tumors had a biomarker related to the drug's target, according to clinical trial results from The University of Texas MD Anderson Cancer Center.

6 Jun 2016

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test v2, a blood-based companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved, blood-based genetic test that can detect epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer patients.

2 Jun 2016

Rash News and Research

Scientists seeking blood donations from people exposed to arboviruses for dengue, Zika vaccine research

Dengue, chikungunya and Zika virus infections can be potential health threat to travelers

Valley fever diagnosis often overlooked by primary care physicians

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

First-line nivolumab promising in advanced NSCLC

Wolbachia bacterium can prevent mosquitoes from transmitting Zika virus

Researchers to explore how Zika virus enters human cells

SLU to conduct human clinical trial of vaccine to protect people from Zika virus

Anti-TNF therapy offers new hope to JDM patients

Utah researchers find way to use power of protease to destroy budding AIDS virus

Type 1 diabetes occurs more frequently in patients with JIA

Zika virus directly infects brain progenitor cells in newborns to cause neurological problems

Experimental drug Rova-T shows safety, efficacy in treating advanced SCLC patients

Nivolumab drug shows better response rate in metastatic bladder cancer patients

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

Study finds decrease in Google searches for chickenpox after vaccination implementation

NMSU researchers seek Aedes aegypti mosquito to map Zika virus transmission

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

EPIC Results Shed Light On First-Line Ponatinib Risk-Benefit Profile

Experimental hepatitis C drug slows down development of Zika in mice

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News